Loading
Latest filing published 09 May 2025 for HCW Biologics Inc., €22k.
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Rick S. Greene on record concern HCW Biologics Inc., in the capacity of board member. Between 25 August 2021 and 8 May 2025, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 3 purchases worth €44k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. 2025 to date brings 1 purchase and no sales.
The median purchase comes to €13k. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 9 May 2025 came the latest disclosure, an open-market purchase for €22k in HCW Biologics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations